Subsequently, ddPCR analysis of a patient derived melanoma cell line (corresponding to a timepoint 12 months after liquid biopsy samples 4 and 9) confirmed the BRAF V600E mutation but not the NRAS Q61R mutation (ddPCR data not shown). This evidence concerns the gene NRAS and melanoma.